What is the risk of placenta accreta during future pregnancies after myomectomy with entry into the endometrial cavity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of Placenta Accreta After Myomectomy with Endometrial Cavity Entry

A. Increase - The risk of placenta accreta is increased in future pregnancies after myomectomy with entry into the endometrial cavity.

Understanding the Mechanism

The pathophysiology directly explains why myomectomy increases accreta risk. The American College of Obstetricians and Gynecologists explains that placenta accreta spectrum develops when defects in the endometrial-myometrial interface lead to failure of normal decidualization in areas of uterine scarring, allowing abnormally deep placental anchoring and trophoblast infiltration 1. When the endometrial cavity is entered during myomectomy, this creates precisely the type of disruption within the uterine cavity that damages the endometrial-myometrial interface, affecting scar tissue development and increasing the likelihood of placenta accreta 1.

Evidence Supporting Increased Risk

  • Prior uterine surgeries are explicitly listed as established risk factors for placenta accreta spectrum by the American College of Obstetricians and Gynecologists, alongside cesarean delivery, curettage, and Asherman syndrome 1.

  • Case reports and observational studies specifically document placenta accreta occurring at myomectomy sites, particularly when the placenta overlies the area of prior uterine surgery 2, 3.

  • Women undergoing cesarean delivery after prior myomectomy face significantly elevated surgical complications, including a 243% increased risk of cesarean hysterectomy (aOR 3.43) and 180% increased risk of intraoperative transfusion (aOR 2.8), suggesting underlying abnormal placentation 4.

Clinical Implications for This Patient

This 30-year-old nulligravid woman now carries a documented risk factor that requires specific management in future pregnancies:

  • She should undergo careful ultrasound evaluation in any subsequent pregnancy to assess for placenta accreta spectrum, particularly if the placenta overlies the myomectomy site 2, 3.

  • If placenta previa develops overlying the myomectomy scar, her risk escalates dramatically - similar to the well-established cesarean scar-previa combination that creates 11-67% accreta risk depending on number of prior surgeries 1.

  • Gray-scale ultrasound should be the first-line imaging modality, looking for loss of the normal hypoechoic retroplacental zone, placental lacunae, thinning of the uterine serosa-bladder interface, and abnormal placental vascularity 5.

Important Caveats

The absolute magnitude of increased risk after myomectomy is not as precisely quantified as it is for cesarean delivery, where systematic reviews show 0.3% risk after one cesarean increasing to 6.74% after five cesareans 1. However, the biological mechanism is identical - uterine scarring disrupting the endometrial-myometrial interface 1.

Entry into the endometrial cavity is particularly significant because it creates a full-thickness defect similar to cesarean delivery, rather than a subserosal defect that would not involve the decidual layer 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Placenta accreta: an association with fibroids and Asherman syndrome.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2008

Research

Placenta increta after hysteroscopic myomectomy.

Obstetrics and gynecology, 2013

Research

Perinatal outcomes of women undergoing cesarean delivery after prior myomectomy.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2020

Guideline

Diagnosing and Managing Placenta Accreta Spectrum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.